Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlenveagh Regulatory News (GLV)

Share Price Information for Glenveagh (GLV)

Share Price is delayed by 15 minutes
Get Live Data
2.36    0.00 (0.00%)
Bid:
2.22
Ask:
2.50
Spread: 0.28 (12.613%)
Market Cap: €1.22b
GLV Live PriceLast checked at - London Stock Exchange

Intraday Glenveagh Share Chart

CFO Transition

5 Sep 2024 07:05

RNS Number : 9715C
Glenveagh Properties plc
05 September 2024
Β 

Β 

Β 

5 September 2024

Β 

Glenveagh Properties plc

Glenveagh Properties plc Announces CFO Transition

Glenveagh Properties plc ("Glenveagh" or the "Group") a leading Irish homebuilder today announces that Michael Rice has informed the Board that he is stepping down from his role as Executive Director and Chief Financial Officer ("CFO") of Glenveagh to pursue other interests. Michael will step down from the Board on 31 December 2024 but will remain with Glenveagh into 2025 to ensure a smooth transition.

Michael will be succeeded in the role of CFO by Conor Murtagh, who is currently Chief Strategy Officer and a member of the Group's Executive Committee. As part of the CFO transition period, the Board will undertake a nomination process in respect of Conor's potential appointment as an Executive Director.

Stephen Garvey said:

I would like to express my deep appreciation for Michael, whose unwavering dedication and exceptional expertise over the past seven years have played a pivotal role in advancing our company to its current position. His hard work and commitment have not only contributed significantly to our success but have also set a strong foundation for the future. We owe much of our progress to his efforts, and we all here at Glenveagh wish him the very best in all his future endeavours.

I am delighted that Conor has agreed to continue to work with the business in the capacity of CFO. Over the past six years, Conor has been a vital part of Glenveagh, consistently demonstrating exceptional leadership, dedication, and a deep understanding of our business and its success drivers. I am confident that Conor will continue to play a crucial role in driving our future success."

Michael Rice added:

"I would like to thank the Board, Stephen and the rest of the senior management team for their support in my time as CFO and Director of Glenveagh and I am very proud of what we have achieved together over the last seven years. I feel now is the right time to move on to new challenges and opportunities. I have every confidence in the future success of the business, and I wish the team the very best for the future."

Conor Murtagh added:

I am excited to assume the role of CFO at Glenveagh. Over the years, I have had the privilege of working closely with the exceptional team at Glenveagh, and I am committed to advancing our shared vision and building on the strong foundation we have established.

ENDS

Β 

Notes to editors:Β 

About Conor Murtagh:

Conor joined Glenveagh in 2018 as Director of Strategy & IR and was appointed Chief Strategy Officer in 2021 where he led the group's Strategy and Corporate Development efforts alongside responsibility for People, L&D and Environmental Health & Safety and Sustainability. Conor joined Glenveagh with over 10 years corporate finance experience from Investec where he advised corporates, PLCs and private equity clients on mergers and acquisitions, disposals, fundraisings and financings.

A fellow of the Association of Chartered Certified Accountants, Conor holds a BBS (Hons, 1st class) in Business Studies from Dublin City University.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOAFFFFIAEISIIS
Date   Source Headline
30th Oct 20247:00 amRNSTransaction in Own Shares
29th Oct 20247:00 amRNSTransaction in Own Shares
28th Oct 20247:00 amRNSTransaction in Own Shares
25th Oct 20247:00 amRNSTransaction in Own Shares
24th Oct 20247:00 amRNSTransaction in Own Shares
23rd Oct 20247:00 amRNSTransaction in Own Shares
22nd Oct 20247:00 amRNSTransaction in Own Shares
21st Oct 20247:00 amRNSTransaction in Own Shares
18th Oct 20247:00 amRNSTransaction in Own Shares
17th Oct 20247:00 amRNSTransaction in Own Shares
16th Oct 20247:00 amRNSTransaction in Own Shares
15th Oct 20247:00 amRNSTransaction in Own Shares
14th Oct 20249:31 amRNSHolding(s) in Company
14th Oct 20247:00 amRNSTransaction in Own Shares
11th Oct 20247:00 amRNSTransaction in Own Shares
10th Oct 20247:00 amRNSTransaction in Own Shares
9th Oct 202410:35 amRNSHolding(s) in Company
9th Oct 20247:00 amRNSTransaction in Own Shares
8th Oct 20247:00 amRNSTransaction in Own Shares
7th Oct 202411:13 amRNSHolding(s) in Company
7th Oct 20247:00 amRNSTransaction in Own Shares
4th Oct 20247:00 amRNSTransaction in Own Shares
3rd Oct 20247:00 amRNSTransaction in Own Shares
2nd Oct 20247:00 amRNSTransaction in Own Shares
1st Oct 202410:39 amRNSTotal Voting Rights
1st Oct 20247:00 amRNSTransaction in Own Shares
30th Sep 202412:32 pmRNSBlock listing Interim Review
30th Sep 20247:00 amRNSTransaction in Own Shares
27th Sep 20247:00 amRNSTransaction in Own Shares
26th Sep 20247:00 amRNSTransaction in Own Shares
25th Sep 20247:00 amRNSTransaction in Own Shares
24th Sep 20247:00 amRNSTransaction in Own Shares
23rd Sep 20247:00 amRNSTransaction in Own Shares
20th Sep 20247:00 amRNSTransaction in Own Shares
19th Sep 20247:00 amRNSTransaction in Own Shares
18th Sep 20242:25 pmRNSHolding(s) in Company
18th Sep 20247:00 amRNSTransaction in Own Shares
17th Sep 20247:00 amRNSTransaction in Own Shares
16th Sep 20247:00 amRNSTransaction in Own Shares
13th Sep 20247:00 amRNSTransaction in Own Shares
12th Sep 20245:27 pmRNSInterim Results 2024
12th Sep 20247:00 amRNSTransaction in Own Shares
11th Sep 20247:00 amRNSTransaction in Own Shares
10th Sep 20249:08 amRNSDirector/PDMR Shareholding
10th Sep 20247:00 amRNSTransaction in Own Shares
9th Sep 20247:00 amRNSTransaction in Own Shares
6th Sep 20247:00 amRNSInitiation of Share Buyback
5th Sep 20247:05 amRNSCFO Transition
5th Sep 20247:00 amRNSInterim Results 2024
2nd Sep 20249:06 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.